PANDOLFO, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 11.491
NA - Nord America 7.988
AS - Asia 4.429
SA - Sud America 1.266
Continente sconosciuto - Info sul continente non disponibili 277
AF - Africa 162
OC - Oceania 26
Totale 25.639
Nazione #
US - Stati Uniti d'America 7.806
RU - Federazione Russa 4.747
IT - Italia 2.160
SG - Singapore 1.764
CN - Cina 1.341
IE - Irlanda 1.212
SE - Svezia 1.098
BR - Brasile 1.073
DE - Germania 512
HK - Hong Kong 464
FR - Francia 419
PL - Polonia 296
UA - Ucraina 250
FI - Finlandia 241
VN - Vietnam 240
GB - Regno Unito 229
IN - India 146
NL - Olanda 83
BD - Bangladesh 80
CA - Canada 77
AR - Argentina 64
TR - Turchia 61
MX - Messico 54
ES - Italia 47
IQ - Iraq 43
ZA - Sudafrica 42
BE - Belgio 39
UZ - Uzbekistan 35
EG - Egitto 33
JP - Giappone 32
PK - Pakistan 32
CO - Colombia 30
MA - Marocco 29
ID - Indonesia 28
AT - Austria 25
PH - Filippine 24
VE - Venezuela 24
EC - Ecuador 23
AU - Australia 22
CZ - Repubblica Ceca 21
CH - Svizzera 20
AE - Emirati Arabi Uniti 15
PE - Perù 13
RO - Romania 13
AZ - Azerbaigian 12
CL - Cile 12
LT - Lituania 12
MY - Malesia 12
PY - Paraguay 12
BY - Bielorussia 11
DZ - Algeria 11
GR - Grecia 11
IL - Israele 10
SA - Arabia Saudita 10
LV - Lettonia 9
NP - Nepal 9
BO - Bolivia 8
KE - Kenya 8
DO - Repubblica Dominicana 7
IR - Iran 7
JO - Giordania 7
TN - Tunisia 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
CR - Costa Rica 6
ET - Etiopia 6
GE - Georgia 6
HN - Honduras 6
JM - Giamaica 6
KG - Kirghizistan 6
PA - Panama 6
SN - Senegal 6
LB - Libano 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
AO - Angola 4
GT - Guatemala 4
KZ - Kazakistan 4
NG - Nigeria 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
OM - Oman 4
SI - Slovenia 4
UY - Uruguay 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
KR - Corea 3
NO - Norvegia 3
RS - Serbia 3
SV - El Salvador 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CG - Congo 2
GY - Guiana 2
KH - Cambogia 2
LK - Sri Lanka 2
ME - Montenegro 2
Totale 25.335
Città #
Moscow 1.310
Dublin 1.212
Ashburn 1.191
Singapore 1.014
Chandler 843
Dallas 773
Nyköping 570
Jacksonville 516
San Jose 504
Beijing 501
Hong Kong 459
Warsaw 278
Los Angeles 192
Rome 180
The Dalles 170
Dearborn 169
Princeton 164
Medford 160
New York 155
Cambridge 142
Milan 139
Lauterbourg 137
Messina 135
Munich 131
Bremen 126
Ann Arbor 124
Des Moines 119
Boardman 111
São Paulo 83
Buffalo 74
Houston 72
Ho Chi Minh City 69
Catania 65
Council Bluffs 64
Turku 64
Redondo Beach 57
Santa Clara 55
Orem 54
Lancaster 49
Frankfurt am Main 47
Tianjin 47
Hanoi 44
Jinan 44
Rio de Janeiro 42
Shenyang 40
Wilmington 38
Guangzhou 37
Brussels 36
Palermo 36
Turin 35
Naples 34
Helsinki 32
Padova 32
Amsterdam 31
Tashkent 31
Woodbridge 31
Belo Horizonte 30
Udine 30
Cairo 29
Hyderabad 29
Brasília 28
San Mateo 28
Brooklyn 27
Chennai 27
Strasbourg 27
Hebei 26
Tokyo 25
Zhengzhou 25
Bari 24
Dong Ket 24
Johannesburg 24
Nanjing 24
Seattle 24
Manchester 23
Pune 23
Vienna 23
Chicago 22
Istanbul 22
Toronto 22
Genoa 21
Phoenix 21
San Francisco 21
London 20
Shanghai 20
Stockholm 20
Atlanta 19
Ningbo 19
Porto Alegre 19
Taranto 19
Bologna 18
Denver 18
Haikou 18
Hangzhou 18
Mexico City 18
Taizhou 18
Verona 18
Washington 18
Baghdad 17
Montreal 17
Poplar 17
Totale 13.848
Nome #
Alessitimia, emozioni negative e comportamento sessuale 469
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 445
State-Trait Anger Expression Inventory (STAXI) e Defense Mechanisms Inventory (DMI): i limiti di un questionario di autovalutazione 439
Il Burnout e l'emozione rabbia. 257
JUVENILE CRIMINALITY AND EXECUTIVE COGNITIVE FUNCTIONING IN AN ITALIAN SAMPLE OF LATE-ONSET ADOLESCENT DELINQUENTS 238
Depressione e disturbi endocrini 237
Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders. 237
Alessitimia, internet addiction disorder e mobile addiction in un campione di adolescenti 230
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia. 224
Indagine statistico-epidemiologica per l’analisi dei rischi dipsicopatologia in giovani affetti da diabete mellito di tipo 1 223
Trattamento con agomelatina in soggetti affetti da fibromialgia: effetti sulla fenomenica depressiva, ansiosa e algica 221
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 221
Carcinoma mammario e disturbo depressivo. 217
Advanced glycation end-products and advanced oxidation protein products in schizophrenia 216
Extrasensory perception experiences and childhood trauma: A rorschach investigation 215
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 210
Valutazione dell’umore e della personalità in un campione di forti fumatori 209
CORRELATION ANALYSIS BETWEEN PERSONALITY AND RESILIENCE IN NON CLINICAL SUBJECTS. 208
Frazione polifenolica del bergamotto per il trattamento della sindrome metabolica nella schizofrenia: uno studio pilota [Bergamot polyphenolic fraction for the treatment of metabolic syndrome in schizophrenia: A pilot study] 208
Anger, Smoking Behavior, and the Mediator Effects of Gender: An Investigation of Heavy and Moderate Smokers. 208
Augmentation con Aripiprazolo vs. placebo nel disturbo ossessivo compulsivo con sintomatologia residua in trattamento stabilizzato con SSRI 205
Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study 204
Alexithymia, Negative Emotions, and Sexual Behavior in Heterosexual University Students from Italy 200
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 198
Psychopharmacotherapy in pregnancy and breastfeeding 196
Comportamento sessuale ed immaginario erotico in donne tossicodipendenti. 195
Morphometrical and morphological analysis of lateral ventricles in schizophrenia patients versus healthy controls. 195
Depression, anxiety and anger in subtypes of irritable bowel syndrome patients 193
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 192
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 188
Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. 187
Cannabis and Sexual Behavior 187
Anger and Adolescence: A Psychometric Investigation on a Sample of Italian High School Students 186
Anger in health, benign breast disease and breast cancer: a prospective case-control study. 186
The wounds of childhood: Early trauma subtypes, salience and hyperarousal in a sample of adult psychiatric patients 186
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 185
Reboxetine add-on to clozapine in treatment of negative symptoms of schizophrenia: a preliminary open-label study 184
Complicated grief: A systematic review of the last 20 years 177
Metabolic outcomes of Red yeast rice administration in patients treated with second-generation antipsychotics 177
Grief and the new DSM-5 clinical category: A narrative review of the literature. 177
Temperamento e alessitimia in un campione di soggetti antisociali con condotte di abuso. 176
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 175
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study 172
EW0245 Cognitive outcomes of Bergamot Polyphenolic Fraction (BPF) supplementation in schizophrenia: Preliminary data 172
Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study 171
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 168
Does personality matter? Temperament and character dimensions in panic subtypes 168
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 166
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder. 166
Lifetime Psychiatric Comorbidity and Diagnostic Trajectories in an Italian Psychiatric Sample 166
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 165
Executive functions and basic symptoms in adolescent antisocial behavior: A cross-sectional study on an Italian sample of late-onset offenders. 165
Donepezil adjunctive treatment to clozapine for cognitive impairment in schizophrenia 164
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 164
Effetto di un trattamento con agomelatina sulle funzioni cognitive/esecutive di un campione di soggetti affetti da fibromialgia 164
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 164
Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia 163
The relationship between sexual behavior and internet addiction severity in a sample of heterosexual university students from Italy. 162
Focus on Disruptive Mood Dysregulation Disorder: A review of the literature 162
Central serous chorioretinopathy and personality characteristics: A systematic review of scientific evidence over the last 10 years (2010 to 2020) 162
IL-33 in Mental Disorders 161
Attentional and mnestic resistance to interference and the positive, negative and disorganization dimensions of schizophrenia: a correlation study 160
Antisocial personality disorder and subthresold symptomatology 160
The role of alexithymia factors in adults with autism spectrum disorder: An explorative study 160
Association between cortisol levels and pain threshold in systemic sclerosis and major depression 160
P.6.d.006 Aripiprazole plus topiramate in opioiddependent patients with schizoaffective disorder: evidence from a pilot study 159
Aripiprazole Plus Topiramate in Opioid-dependent Patients with Schizoaffective Disorder: An 8-week, Open-label, Uncontrolled, Preliminary Study 159
Esplorazione neuropsicologica del lobo prefrontale nel disturbo schizofrenico 157
Esplorazione neuropsicologica delle funzioni esecutive 157
Aspetti funzionali dei recettori D1 Mesocorticali 155
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 155
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 153
Vortioxetine on Cognition in Schizophrenia: A Pilot Study 152
The Relationship between Anger and Heterosexual Behavior. An Investigation in a Nonclinical Sample of Urban Italian Undergraduates. 151
Indici psicodiagnostici dei disturbi dello spettro autistico in età adulta: risultati preliminari 150
Funzioni neuropsicologiche e dimensioni psicopatologiche (positiva, negativa e disorganizzata) della schizofrenia. 149
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 149
The Relationship Between Anger and Sexual Behavior: A Review of Theories and Research 149
Meccanismi di difesa (D.M.I.) e temperamento (T.C.I.): studio di correlazione. 148
Criminalità giovanile: correlati neuropsicologici e psicopatologici. 148
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 148
Effect of Red Yeast Rice on Cognitive Functioning in Schizophrenia: Data from a Pilot Study 148
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 146
EFFECT OF ZIPRASIDONE AUGMENTATION OF SEROTONIN REUPTAKE INHIBITORS IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER 145
The Role of Basic Symptoms and Aberrant Salience in Borderline Personality Disorder 145
P.4.d.002 Effect of ziprasidone augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder 144
Personality traits and emotional patterns in irritable bowel Syndrome 142
Correlazione tra sintomi di base e dimensione psicotica nel disturbo schizofrenico 141
Memoria ed attenzione nel disturbo ossessivo compulsivo: uno studio preliminare. 139
Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study 139
Effect of valproate on plasma concentrations of olanzapine in patients with psychotic disorders , July, 2009, MP 110.. 137
Metabolic Outcomes of Bergamot Polyphenolic Fraction Administration in Patients Treated with Second-Generation Antipsychotics: a Pilot Study 136
Indagine statistico-epidemiologica per l’analisi dei rischi di psicopatologia in adolescenti affetti da diabete mellito di tipo1. 135
Reboxetine adjuvant therapy in patients with schizophrenia showing a suboptimal response to clozapine: a 12-week, open-label, pilot study. 133
Sharing the same perspective. Mental disorders and central serous chorioretinopathy: A systematic review of evidence from 2010 to 2020 133
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 131
Workplace violence against healthcare professionals: A systematic review 131
Comportamento sessuale ed immaginario erotico ad un test proiettivo in un campione di donne messinesi. 130
L'instabilità affettiva nel Disturbo Borderline di Personalità e nella Ciclotimia. 130
Temperamento, carattere e motivazione sessuale. 129
Totale 18.119
Categoria #
all - tutte 80.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.297 0 145 30 51 58 12 74 52 66 273 152 384
2022/20233.523 230 334 155 226 379 335 38 182 1.469 40 96 39
2023/20241.321 93 160 103 134 112 245 57 64 36 99 71 147
2024/20253.964 70 77 151 261 191 180 92 732 916 214 418 662
2025/202611.441 654 709 818 667 910 2.287 1.448 1.433 1.460 582 233 240
2026/2027304 221 83 0 0 0 0 0 0 0 0 0 0
Totale 25.639